We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$104B
AUM Growth
+$9.45B
Cap. Flow
+$9.9B
Cap. Flow %
9.52%
Top 10 Hldgs %
28.08%
Holding
8,130
New
449
Increased
3,536
Reduced
3,324
Closed
388

Sector Composition

Rank Sector Weight
1 Healthcare 5.43%
2 Energy 4.72%
3 Technology 4.42%
4 Financials 3.4%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCF
7601
High Income Securities Fund
PCF
$99.9M
-58
Closed
PCRX icon
7602
CALL
Pacira BioSciences
PCRX
$997M
-2,000
Closed -$182K
PCYO icon
7603
Pure Cycle
PCYO
$261M
$0 ﹤0.01%
+44
New +$290
PDS
7604
CALL
Precision Drilling
PDS
$974M
-155
Closed -$43K
PDT
7605
John Hancock Premium Dividend Fund
PDT
$626M
$0 ﹤0.01%
+38
New +$505
PFD
7606
Flaherty & Crumrine Preferred and Income Fund
PFD
$146M
$0 ﹤0.01%
1
PGJ icon
7607
Invesco Golden Dragon China ETF
PGJ
$98.7M
-235
Closed -$7K
PHIO icon
7608
Phio Pharmaceuticals
PHIO
$12.1M
0
-$8K
PIM
7609
Franklin Master Intermediate Income Trust
PIM
$151M
$0 ﹤0.01%
+4
New +$20
PLX icon
7610
Protalix BioTherapeutics
PLX
$198M
$0 ﹤0.01%
6
POST icon
7611
CALL
Post Holdings
POST
$3.57B
-126,824
Closed -$4.15M
PPT
7612
Franklin Premier Income Trust
PPT
$328M
-30
Closed
PRDO icon
7613
CALL
Perdoceo Education
PRDO
$2.12B
-77,700
Closed -$311K
PRDO icon
7614
PUT
Perdoceo Education
PRDO
$2.12B
-14,700
Closed -$59K
PRSO icon
7615
Peraso
PRSO
$11.3M
0
PSO icon
7616
Pearson
PSO
$9.9B
-86,033
Closed -$1.64M
CNSY
7617
Cerenome, Inc. Common Stock
CNSY
$26.4M
0
BCIC
7618
BCP Investment Corp
BCIC
$92.9M
-890
Closed -$71K
PYZ icon
7619
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$77.8M
-345
Closed -$19K
PZG icon
7620
Paramount Gold Nevada
PZG
$124M
$0 ﹤0.01%
14,037
-18,546
-57% -$18.1K
PZZA icon
7621
CALL
Papa John's
PZZA
$806M
-4,000
Closed -$168K
QRHC icon
7622
Quest Resource Holding
QRHC
$31.6M
$0 ﹤0.01%
17
-18
-51% -$555
RAMP icon
7623
CALL
LiveRamp
RAMP
$2.3B
-1,000
Closed -$21K
RBBN icon
7624
CALL
Ribbon Communications
RBBN
$383M
-80
Closed -$1K
RDNT icon
7625
CALL
RadNet
RDNT
$5.69B
-7,800
Closed -$47K

Similar funds

Barclays's Q3 2014 Portfolio in Review

As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.

  • Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
  • Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
  • Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
  • Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
  • Barclays opened 449 new positions and closed 388 in Q3 2014.
  • Barclays's portfolio value rose 10% quarter-over-quarter to $104B.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.